DMPV
Delphi Management Partners VIII Portfolio holdings
AUM
$138M
This Quarter Return
+7.04%
1 Year Return
+56.76%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$127M
AUM Growth
+$127M
(-13%)
Cap. Flow
-$26M
Cap. Flow
% of AUM
-20.53%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Senseonics Holdings
SENS
|
$26M |
Sector Composition
| 1 | Healthcare | 95.99% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tandem Diabetes Care
TNDM
$834M
| $97.4M | 76.91% |
1,000,000
| – | – |
|
2
Karyopharm Therapeutics
KPTI
$61.4M
| $23.4M | 18.44% |
2,263,006
| – | – |
|
|
CALA
3
DELISTED
Calithera Biosciences, Inc
CALA
| $5.07M | 4.01% |
2,426,702
| – | – |
|
|
MREO
4
Mereo BioPharma
MREO
$275M
| $814K | 0.64% |
256,734
| – | – |
|
|
5
Senseonics Holdings
SENS
$368M
| – | – |
-9,846,294
| Closed | -$26M |
|